Cite

    Kamal, R. et al. (2017). Addition of Mycobacterium indicus pranii vaccine as an immunotherapeutic to standard chemotherapy in borderline leprosy: a double‐blind study to assess clinical improvement (preliminary report). British journal of dermatology. pp. 1388-1389. [Online].